<DOC>
	<DOCNO>NCT00886249</DOCNO>
	<brief_summary>The purpose study evaluate compare depth focus visual outcome implantation Acrysof IQ SN60WF aspheric intraocular lens ( IOL ) Acrysof Natural SN60AT spherical IOL .</brief_summary>
	<brief_title>Depth Focus Comparison Between Acrysof IQ Acrysof Natural IOLs</brief_title>
	<detailed_description>Cataract prevalent throughout world IOLs routinely implant extraction cataractous lens . It frequently perform surgery United States estimate 2-3 million procedure perform annually . With age population rise , well increase popularity refractive intraocular lens , number intraocular surgery continue rise . Over year , evolution IOLs broaden surgeon 's armamentarium follow cataract extraction . Traditionally spherical IOLs routinely implant follow cataract extraction correction aphakia . Even though IOLs improve patient vision 20/20 time , nott address spherical aberration optical system . Normally cornea positive spherical aberration . Spherical aberration mean light ray fall eye 's periphery either ( positive spherical aberration ) less ( negative spherical aberration ) refract axial ray . Such aberration usually affect functional vision patient contrast sensitivity , depth focus ( ability see far , near intermediate ) perception glare halo . Corneal spherical aberration adequately neutralized negative spherical aberration crystalline lens age 40 . ( 1 ) When cataractous lens remove , corneal spherical aberration longer neutralized optical system net positive spherical aberration . Conventional IOLs implant phacoemulsification result spherical aberration approximately 0.08 µm add already positive corneal aberration eye . ( 2 , 3 ) In order patient reach optimal functional vision , effort lead development aspheric IOLs . Aspheric IOLs compensate positive spherical aberration cornea . They show improve functional vision optical quality pseudophakic patient . ( 4 , 5 ) Acrysof IQ , aspheric IOL introduce gain FDA approval May 2006 . Its share basic design feature Acrysof Natural IOL modification optic design acquire posterior prolate surface reduce central thickness . Unlike cornea , introduces negative spherical aberration ( 0.2 µm ) lower spherical aberration eye . ( 6 ) It report provide good contrast sensitivity , quality vision few aberration aspheric IOL compare conventional ( spherical ) IOL . ( 6,7,8 ) However , study find conventional ( spherical ) IOLs good depth focus aspheric IOLs allow patient achieve good intermediate near vision . ( 5 ) Conversely , Mester et al find difference depth focus IOLs . ( 7 ) The purpose study evaluate compare depth focus visual outcomes eye receive aspheric Acrysof IQ receive spherical Acrysof Natural IOL routine cataract extraction .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Patient Subject must agerelated cataract eye ; Subject must 40 year age old ; Subject must desire cataract extraction ; Expected maximum 2 week minimum 1 week interval first second eye surgery ; AND Subject must willing able comply schedule visit study procedure . Patient Preoperative ocular pathology : amblyopia , shallow anterior chamber , aniridia , history iritis , iris neovascularization iris atrophy , uveitis , medically uncontrolled glaucoma advance glaucomatous damage , rubella cataract , diabetic retinopathy , macular edema , retinal detachment , microphtalmus macrophtalmus , optic nerve atrophy , macular degeneration ( anticipated best postoperative visual acuity le 20/30 ) , etc . ; Keratometric astigmatism exceed 1.5 diopter ; Uncontrolled diabetes ; Use systemic topical drug know interfere visual performance ; Contact lens use active treatment portion trial ; Any concurrent infectious/non infectious conjunctivitis , keratitis uveitis ; Pregnant nursing mother females childbearing potential practicing reliable medically acceptable method birth control ; Any clinically significant , serious severe medical psychiatric condition may increase risk associate study participation study device implantation may interfere interpretation study result ; Participation ( current participation ) investigational drug device trial within previous 30 day prior start date trial . Prior history eye surgery ; Other ocular surgery time cataract extraction ( except limbal relax incision , LRI ) ; OR History trauma . Surgical The study lens implanted patient exclude study follow complication encounter surgery : Significant anterior chamber bleeding ; Detached Descemet 's membrane ; Iris damage ; Inability achieve secure , symmetric , `` bag '' position IOL : posterior capsule rupture , radial tear capsulorhexis , vitreous loss , zonular rupture ; OR Use corneal suture 1 week . Postimplantation Haptic capsular bag ; Decentration IOL 1.0 mm ; OR Ocular pathology potentially affect visual acuity evident prior surgery .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Vision</keyword>
	<keyword>Eye</keyword>
	<keyword>Cataract</keyword>
</DOC>